glp 1/gip agonist Frontiers GI Adverse Effects of Glucagon-Like
Description
Deng, F
Chen, J
The results of a trial of semaglutide in obese patients with HFpEF showed a significant amelioration of symptoms and improvements in motor function and weight loss compared with patients treated with a placebo
doi: 10.1016/j.ejphar.2008.03.025 172 GenglerSMcCleanPLMcCurtinRGaultVAHolscherC
patients describe a quietening of what many in the clinical community now refer to as food noise, the persistent neurological signal that drives overconsumption independent of genuine caloric need
Back Dupr, J (26 Sept 1964) 'An intestinal hormone affecting glucose disposal in man', The Lancet , 672-73
